Delivery Order SPE2DB22D1103-SPE2DB24FTLZ5
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML pharmaceutical products. The firm-fixed price Delivery Order contract, valued at $1,464.64, was awarded by the Defense Agency Defense Logistics Agency Troop Support Medical on May 6, 2024 with a completion date of May 7, 2024. This award is not set-aside. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the Defense...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $2,163.18 and was awarded on May 20, 2024, with a completion date of May 21, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Firm Fixed Price Delivery Order contract valued at $2,890.59. The contract is to provide LANTUS SOLOSTAR 100 UNIT/ML 3ML to the Defense Logistics Agency (DLA) Troop Support Medical, with an ultimate completion date of July 15, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as...
- This federal contract award to Amerisourcebergen Drug Corp, awarded by the Defense Logistics Agency (DLA), is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a pharmaceutical product. The ceiling value of this Firm Fixed Price Delivery Order contract is $1,501.92, with a period of performance through May 28, 2024. Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of the Amerisourcebergen Corporation, is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML pharmaceuticals. The $2,903.32 firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA), a defense agency, on April 30, 2024 with a completion date of May 1, 2024. The contract does not have a set-aside designation. Amerisourcebergen holds a significant $999,999,999.00...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML pharmaceutical products. The contract, valued at $1,198.81, was awarded on May 30, 2024 by the Defense Logistics Agency (DLA), a defense agency, with an ultimate completion date of May 31, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued up to $999,999,999.00 through...
- Amerisourcebergen Drug Corp, through its Corporate Office division, has been awarded a firm fixed price delivery order contract (SPE2DX15D3015|SPE2DX24F0GR0) by the Defense Logistics Agency (DLA) Troop Support Medical to supply LANTUS SOLOSTAR 100 UNIT/ML 3ML pharmaceuticals. The award has a ceiling value of $2,495.23 and a period of performance through March 25, 2024. This delivery order is issued under an indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA with a...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML pharmaceutical products. The contract, awarded by the Defense Logistics Agency (DLA), has a ceiling value of $2,444.79 and a completion date of April 29, 2024. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31,...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a prescription medication, to the U.S. government. The contract has a ceiling value of $1,187.60 and is a firm-fixed price Delivery Order awarded by the Defense Logistics Agency (DLA) Troop Support Medical, which is part of the Department of Defense (DoD). Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) valued at up...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product LANTUS SOLOSTAR 100 UNIT/ML 3ML. The contract has a ceiling value of $2,375.20 and was awarded on May 10, 2024, with a completion date of May 13, 2024. The contract is a Delivery Order under a Firm Fixed Price pricing type. The awarding agency is the Defense Logistics Agency (DLA) Troop Support Medical, which is part of the U.S. Department of Defense (DoD)....
- SPE2DB22D1103Indefinite Delivery Contract
- SPE2DB22D1103-SPE2DB24FTLZ5Delivery Order
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a pharmaceutical product, with a ceiling value of $1,263.80. The contract, awarded by the Defense Logistics Agency (DLA), is a Delivery Order contract with a Firm Fixed Price pricing type. The award has no set-aside designation and the ultimate completion date is June 11, 2024. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through December 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 6/10/24 |